Research programme: calcitonin gene-related peptide - Unigene LaboratoriesAlternative Names: Research programme: CGRP - Unigene Laboratories
Latest Information Update: 21 Apr 2011
At a glance
- Originator Unigene Laboratories
- Class Neuropeptides
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 04 Apr 2008 Preclinical trials in Congestive heart failure in USA (unspecified route)